首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltration technique for the determination of plasma protein binding of three coumarins using acetone as protein binding releasing agent
【24h】

Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltration technique for the determination of plasma protein binding of three coumarins using acetone as protein binding releasing agent

机译:新型中空纤维离心超滤技术预处理血浆样品,以丙酮为蛋白质结合释放剂测定三种香豆素的血浆蛋白结合

获取原文
获取原文并翻译 | 示例
           

摘要

A novel and practical sample pretreatment method based on hollow fiber centrifugal ultrafiltration (HFCF-UF) was developed to determine plasma protein binding by using HPLC. The samples for analyzing unbound and total concentrations could be prepared in parallel simultaneously by the same device. It only required centrifugation for a short time and the filtrate could be injected directly for HPLC analysis without further treatment. Coumarins were selected as the model drugs. Acetone was chosen as the releasing agent to free the binding drug from the drug-protein complex for the total drug concentration determination. Non-specific bindings (NSBs) between the analytes and hollow fiber membrane materials were investigated. The type and volume of protein binding releaser were optimized. Additionally, centrifugal speed and centrifugal time were considered. Under the optimized conditions, the absolute recovery rates of the unbound and total concentrations were in the range of 97.5-100.9% for the three analytes. The limits of detection were in the range of 0.0135-0.0667 mu g mL(-1). In vitro plasma protein binding of the three coumarins was determined at three concentrations using the validated method and the relative standard deviations (RSDs) were less than 3.4%. Compared with traditional method, the HFCF-UF method is simple to run, no specialized equipment requirement and is a more accurate plasma pretreatment procedure with almost excellent drug-protein binding equilibrium. Therefore, this method can be applied to determine the plasma protein binding in clinical practice. It also provides a reliable alternative for accurate monitoring of unbound or total drug concentration in therapeutic drug monitoring (TDM). (C) 2015 Elsevier B.V. All rights reserved.
机译:建立了一种基于空心纤维离心超滤(HFCF-UF)的新颖实用的样品前处理方法,以通过HPLC测定血浆蛋白的结合。可以通过同一设备同时并行制备用于分析未结合浓度和总浓度的样品。仅需短时间离心,滤液就可直接注入进行HPLC分析,而无需进一步处理。选择香豆素作为模型药物。选择丙酮作为释放剂,以从药物-蛋白质复合物中释放结合药物,以测定总药物浓度。研究了分析物和中空纤维膜材料之间的非特异性结合(NSB)。优化了蛋白结合释放剂的类型和体积。另外,考虑了离心速度和离心时间。在优化的条件下,三种分析物的未结合浓度和总浓度的绝对回收率在97.5-100.9%的范围内。检测限在0.0135-0.0667μg mL(-1)范围内。使用验证的方法在三种浓度下测定了三种香豆素的体外血浆蛋白结合,相对标准偏差(RSD)小于3.4%。与传统方法相比,HFCF-UF方法操作简单,无需专门的设备,是一种更精确的血浆预处理程序,几乎具有优异的药物-蛋白质结合平衡。因此,该方法可用于临床实践中测定血浆蛋白结合。它还为在治疗药物监控(TDM)中准确监控未结合或总药物浓度提供了可靠的替代方法。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号